Day: March 17, 2023

Airport Ground And Cargo Handling Service Market is Expected to Surpass USD 29.35 Billion by 2030 at a CAGR of 7.2% from 2022 to 2030; Growth in Air Traffic, Expansion in Airport and E-commerce, and Globalization Drive the Market.

Written by Customer Service on March 17, 2023. Posted in Mergers And Acquisitions.

SkyQuest’s report on the market for airport ground and cargo handling services market is a highly informative resource for those looking to gain a deeper understanding of this rapidly expanding industry. The report is written in a clear and concise manner, making it accessible to a broad audience ranging from industry specialists to lay readers. Furthermore, it provides a comprehensive analysis of both primary and secondary market drivers, which grants readers a thorough understanding of the current state of the market as well as future projections. Westford USA, March 17, 2023 (GLOBE NEWSWIRE) — The Airport Ground and Cargo Handling Services industry is anticipated to grow substantially in the North American and Asia Pacific regions, driven by various factors. These factors comprise the growth in air traffic, the surge in...

Leak Detection and Repair Market is Projected to Cross USD 25.64 Billion by 2028 at a CAGR of 4.7% during 2022-2028; Increasing Regulatory Requirements and Expansion of the Oil and Gas Industry to Boost Market Growth

Written by Customer Service on March 17, 2023. Posted in Mergers And Acquisitions.

The leak detection and repair market demands constant adaptation to remain competitive. To this end, businesses need to be aware of the latest trends and advancements in the market. Fortunately, SkyQuest’s latest report offers valuable insights into the industry’s key growth areas and innovations, making it an indispensable resource for those seeking to stay ahead of the curve. The benefits of utilizing reports extend beyond simply keeping up with the competition. Businesses can achieve increased profitability and improved customer satisfaction by taking a proactive approach to the market and implementing the latest advancements. They can also position themselves as leaders in the field, setting the standard for others to follow. Westford, USA, March 17, 2023 (GLOBE NEWSWIRE) — The leak detection and repair market is...

Kering: Statement in compliance with article 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) (March 2023)

Written by Customer Service on March 17, 2023. Posted in Public Companies.

Kering – Statement Number of Shares and voting rights – 03.15.2023 Kering Société anonyme with a capital of € 496,283,112 Head office : 40, rue de Sèvres – 75007 PARIS 552 075 020 RCS PARIS March 17, 2023 Statement in compliance with article 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) Date Total Number of shares Total number of voting rights theoretical 1 Exercisable 2 March 15, 2023 124,070,778 177,012,194 175,235,251 1 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). 2 Excluding treasury shares stripped of voting rights. Attachment...

United-Guardian Reports 2022 Financial Results

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

HAUPPAUGE, N.Y., March 17, 2023 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) reported that net income for FY 2022 decreased by 45% compared to FY 2021. Net sales for the year decreased by 9% from $13,929,629 in 2021 to $12,698,503 in 2022, generating net income of $2,569,512 ($0.56 per share) in 2022 compared to $4,658,542 ($1.01 per share) in 2021. Beatriz Blanco, President of United-Guardian, stated, “The decrease in the Company’s net income was primarily caused by a decrease in revenue of our cosmetic ingredients combined with increased losses from our marketable securities portfolio. The main factors which negatively impacted the sales of our cosmetic ingredients were 1) overstocking by certain contract manufactures in 2021, in an effort to avoid potential supply chain issues in 2022, and 2) lower demand in Asia, especially...

Healthcare Integrated Technologies, Inc. Announces Approval of U.S. Patent for Fall Validation with Privacy-Aware Monitoring System

Written by Customer Service on March 17, 2023. Posted in Public Companies.

Knoxville, Tennessee, March 17, 2023 (GLOBE NEWSWIRE) — Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, is proud to announce the approval of U.S. Patent 11,587,423, issued on February 21, 2023. The patent is titled “Fall Validation with Privacy-Aware Monitoring” and was developed by inventors Kenneth M. Greenwood, Scott M. Boruff, and Jurgen K. Vollrath. The patent application, initially filed on July 30, 2021, followed a provisional application filed on August 3, 2020. The patented technology describes a method and system for detecting a person falling, confirming a potential fall, and taking action to mitigate the effects of a fall. The system is designed with privacy in mind, ensuring that sensitive data is protected without compromising the effectiveness...

Diana Shipping Inc. Announces Time Charter Contract for m/v Leonidas P. C. With Cargill

Written by Customer Service on March 17, 2023. Posted in Public Companies.

ATHENS, Greece, March 17, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International S.A., Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Leonidas P. C. The gross charter rate is US$17,000 per day, minus a 4.75% commission paid to third parties, for a period of minimum eleven (11) months to maximum thirteen (13) months. The charter commenced earlier today. The “Leonidas P. C.” is a 82,165 dwt Kamsarmax dry bulk vessel built in 2011. The employment of “Leonidas P. C.” is anticipated to generate approximately US$5.61 million of gross revenue for the minimum scheduled period...

Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting

Written by Customer Service on March 17, 2023. Posted in Public Companies.

Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been submitted in major markets including U.S. and EuropeAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans. Earlier this year, Alvotech announced two regulatory updates for AVT04. In February 2023 Alvotech announced that a Marketing Authorization Application...

Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting

Written by Customer Service on March 17, 2023. Posted in Public Companies.

Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been submitted in major markets including U.S. and EuropeREYKJAVIK, Iceland, March 17, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans. Earlier this year, Alvotech announced two regulatory updates for AVT04. In February 2023 Alvotech...

SeqLL Announces Fourth Quarter and Year End 2022 Financial Results

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

BILLERICA, Mass., March 17, 2023 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services, today announced its operating and financial results for the fourth quarter and year ended December 31, 2022. Year End 2022 Results and Financial HighlightsTotal revenues for the year ended December 31, 2022 were $0.079 million compared to $0.21 million during the year ended December 31, 2021, representing a decrease of 63%. The change in revenue was primarily a result of the reduction in research services and business activities due to the slow-down during the COVID-19 pandemic.Gross profits were $0.078 million for the year ended December 31, 2022; as compared to $.15 million for the year ended December 31, 2021. The change represents...

Dynagas LNG Partners LP Reports Results for the Three Months and Year Ended December 31, 2022

Written by Customer Service on March 17, 2023. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, March 17, 2023 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three months and year ended December 31, 2022. Year Highlights:Net Income and earnings per common unit (basic and diluted) of $54.0 million and $1.15, respectively; Adjusted Net Income(1) of $30.6 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.52; Adjusted EBITDA(1) of $89.5 million; 100% fleet utilization(2);Fourth Quarter Highlights:Net Income and earnings per common unit (basic and diluted) of $11.6 million and $0.24, respectively; Adjusted Net Income(1) of $7.0 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.11; Adjusted EBITDA(1) of $23.6 million; 100%...

Day: March 17, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals